Index 
 Previous 
 Next 
 Full text 
Procedure : 2018/2775(RSP)
Document stages in plenary
Select a document :

Texts tabled :

O-000122/2018 (B8-0001/2019)

Debates :

PV 12/02/2019 - 24
CRE 12/02/2019 - 24

Votes :

Texts adopted :


Minutes
Tuesday, 12 February 2019 - StrasbourgFinal edition

24. Use of cannabis for medicinal purposes (debate)
CRE

Question for oral answer (O-000122/2018) by Dubravka Šuica, Guillaume Balas, Urszula Krupa, Catherine Bearder, Estefanía Torres Martínez, Martin Häusling and Piernicola Pedicini, on behalf of the ENVI Committee, to the Commission: Use of cannabis for medicinal purposes (B8-0001/2019)

Dubravka Šuica moved the question.

Věra Jourová (Member of the Commission) answered the question.

The following spoke Peter Liese, on behalf of the PPE Group, Guillaume Balas, on behalf of the S&D Group, Urszula Krupa, on behalf of the ECR Group, and Luke Ming Flanagan, on behalf of the GUE/NGL Group.

The following spoke: Věra Jourová.

Motion for a resolution to wind up the debate tabled under Rule 128(5):

—   Dubravka Šuica, Guillaume Balas, Urszula Krupa, Catherine Bearder, Estefanía Torres Martínez, Martin Häusling and Piernicola Pedicini, on behalf of the ENVI Committee, on use of cannabis for medicinal purposes (2018/2775(RSP)) (B8-0071/2019).

The debate closed.

Vote: minutes of 13.2.2019, item 16.11.

Last updated: 5 August 2019Legal notice